Brief: Sun Pharma Advanced Research Decides To Close Proseek Study Of Vodobatinib

Sun Pharma Advanced Research

10/04/2024 04:07

April 10 (Reuters) - Sun Pharma Advanced Research Co Ltd
 SPRC.NS :
    * SPARC ANNOUNCES RESULTS FROM PLANNED INTERIM ANALYSIS OF
PROSEEK
STUDY OF VODOBATINIB IN PATIENTS WITH EARLY PARKINSON'S DISEASE
    * SPARC HAS DECIDED TO CLOSE ONGOING PROSEEK STUDY
    * SPARC HAS REVIEWED DATA AND DETERMINED THAT STUDY HAS NOT
SHOWN
EVIDENCE OF TREATMENT BENEFIT IN PATIENTS RECEIVING VODOBATINIB
    * DECIDED TO CLOSE STUDY
    * PLANS TO COMPLETE FULL ANALYSIS OF CLINICAL OUTCOMES AND
CORRELATIVE BIOMARKER DATA IN COMING MONTHS

Source text for Eikon:  ID:nBSEbzwBd0 
Further company coverage:  SPRC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))